Full Text View
Tabular View
No Study Results Posted
Related Studies
Insulin Glargine in Type 2 Diabetes Mellitus
This study has been completed.
Study NCT00311818   Information provided by Sanofi-Aventis
First Received: April 5, 2006   Last Updated: September 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes Mellitus
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Insulin glargine
Additional drug interventions recognized in this trial
Glargine
Hypoglycemic Agents
Insulin
More general drug interventions related to this trial
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services